These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21171883)

  • 1. Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease.
    Fleury A; Carrillo-Mezo R; Flisser A; Sciutto E; Corona T
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):123-33. PubMed ID: 21171883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurocysticercosis].
    del Brutto OH
    Rev Neurol; 1999 Sep 1-15; 29(5):456-66. PubMed ID: 10584250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurocysticercosis].
    Duchêne M; Benoudiba F; Iffenecker C; Hadj-Rabia M; Caldas J; Doyon D
    J Radiol; 1999 Dec; 80(12):1623-7. PubMed ID: 10642655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of 3D magnetic resonance imaging sequences in diagnosing basal subarachnoid neurocysticercosis.
    Carrillo Mezo R; Lara García J; Arroyo M; Fleury A
    Acta Trop; 2015 Dec; 152():60-65. PubMed ID: 26327445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocysticerosis: An Individualized Approach.
    Coyle CM
    Infect Dis Clin North Am; 2019 Mar; 33(1):153-168. PubMed ID: 30712759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocysticercosis.
    Del Brutto OH
    Semin Neurol; 2005 Sep; 25(3):243-51. PubMed ID: 16170737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host and environmental factors.
    Fleury A; Escobar A; Fragoso G; Sciutto E; Larralde C
    Trans R Soc Trop Med Hyg; 2010 Apr; 104(4):243-50. PubMed ID: 20116079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the burden and spatial distribution of Taenia solium human neurocysticercosis in Ecuador (2013-2017).
    Coral-Almeida M; Henriquez-Trujillo AR; Asanza S; Erazo C; Paucar M; Calvopiña M
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008384. PubMed ID: 32511228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Giant racemose subarachnoid and intraventricular neurocysticercosis: A case report].
    Sanchez-Larsen A; Monteagudo M; Lozano-Setien E; Garcia-Garcia J
    Rev Argent Microbiol; 2015; 47(3):201-5. PubMed ID: 26321177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical manifestations of neurocysticercosis].
    San-juan Orta D
    Neurologia; 2009 Jun; 24(5):331-5. PubMed ID: 19642036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population Screening for Urine Antigens to Detect Asymptomatic Subarachnoid Neurocysticercosis: A Pilot Study in Northern Peru.
    McCleery E; Allen SE; Moyano LM; Gamboa R; Vilchez P; Muro C; Castillo Y; Dorny P; Garcia HH; O'Neal SE;
    Am J Trop Med Hyg; 2020 Sep; 103(3):1125-1128. PubMed ID: 32602434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of neurocysticercosis and epilepsy, is everything described?
    Tellez-Zenteno JF; Hernandez-Ronquillo L
    Epilepsy Behav; 2017 Nov; 76():146-150. PubMed ID: 28526213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocysticercosis: radiologic-pathologic correlation.
    Kimura-Hayama ET; Higuera JA; Corona-Cedillo R; Chávez-Macías L; Perochena A; Quiroz-Rojas LY; Rodríguez-Carbajal J; Criales JL
    Radiographics; 2010 Oct; 30(6):1705-19. PubMed ID: 21071384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracranial mass lesions in HIV/AIDS patients from developing countries endemic for neurocysticercosis.
    Lattuada E; Lanzafame M; Concia E; Vento S
    Int J STD AIDS; 2007 Feb; 18(2):144-5. PubMed ID: 17331296
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurocysticercosis: a review.
    Hawk MW; Shahlaie K; Kim KD; Theis JH
    Surg Neurol; 2005 Feb; 63(2):123-32; discussion 132. PubMed ID: 15680651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology of cysticercosis and neurocysticercosis].
    Bouteille B
    Med Sante Trop; 2014; 24(4):367-74. PubMed ID: 25296005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurocysticercosis: updated concepts about an old disease.
    Garcia HH; Del Brutto OH;
    Lancet Neurol; 2005 Oct; 4(10):653-61. PubMed ID: 16168934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of neurocysticercosis.
    Ramírez-Zamora A; Alarcón T
    Neurol Res; 2010 Apr; 32(3):229-37. PubMed ID: 20406600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of
    Toribio L; Romano M; Scott AL; Gonzales I; Saavedra H; Garcia HH; Shiff C; For The Cysticercosis Working Group In Peru
    Am J Trop Med Hyg; 2019 Feb; 100(2):327-329. PubMed ID: 30526736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical aspects of neurocysticercosis.
    Takayanagui OM; Odashima NS
    Parasitol Int; 2006; 55 Suppl():S111-5. PubMed ID: 16330240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.